Using eclipse scripting to fully automate in-vivo image analysis to improve treatment quality and safety.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 13 01 2022
received: 18 11 2021
accepted: 23 02 2022
pubmed: 23 3 2022
medline: 16 6 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

An automated, in-vivo system to detect patient anatomy changes and machine output was developed using novel analysis of in-vivo electronic portal imaging device (EPID) images for every fraction of treatment on a Varian Halcyon. In-vivo approach identifies errors that go undetected by routine quality assurance (QA) to compliment daily machine performance check (MPC), with minimal physicist workload. Images for all fractions treated on a Halcyon were automatically downloaded and analyzed at the end of treatment day. For image analysis, compared to first fraction, the mean difference of high-dose region of interest is calculated. This metric has shown to predict changes in planning treatment volume (PTV) mean dose. Flags are raised for: (Type-A) treatment fraction whose mean difference exceeds 10%, to protect against large errors, and (Type-B) patients with three consecutive fractions with mean exceeding ±3%, to protect against systematic trends. If a threshold is exceeded, a physicist is e-mailed, a report for flagged patients, for investigation. To track machine output changes, for all patients treated on a day, the average and standard deviations are uploaded to a QA portal, along with the reviewed MPC, ensuring comprehensive QA for the Halcyon. To guide clinical implementation, a retrospective study from November 2017 till December 2020 was conducted, which grouped errors by treatment site. This framework has been used prospectively since January 2021. From retrospective data of 1633 patients (35 759 fractions), no Type-A errors were found and only 45 patients (2.76%) had Type-B errors. These Type-B deviations were due to head-and-neck weight loss. For 6 months of prospective use (345 patients), 13 patients (3.7%) had Type-B errors and no Type-A errors. This automated system protects against errors that can occur in vivo to provide a more comprehensive QA. This fully automated framework can be implemented in other centers with a Halcyon, requiring a desktop computer and analysis scripts.

Identifiants

pubmed: 35315570
doi: 10.1002/acm2.13585
pmc: PMC9194972
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13585

Subventions

Organisme : Varian Medical Systems
ID : 20195180

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Med Phys. 2015 Sep;42(9):5363-9
pubmed: 26328985
Adv Radiat Oncol. 2019 Apr 12;4(4):722-728
pubmed: 31681865
Med Phys. 2018 Jun 13;:
pubmed: 29896916
Med Phys. 1998 May;25(5):656-61
pubmed: 9608475
J Appl Clin Med Phys. 2007 Jul 17;8(3):76-90
pubmed: 17712302
Diagnostics (Basel). 2021 Sep 09;11(9):
pubmed: 34573994
J Appl Clin Med Phys. 2019 Jun;20(6):79-90
pubmed: 31083776
Med Phys. 2015 Dec;42(12):6912-8
pubmed: 26632047
J Appl Clin Med Phys. 2022 Jun;23(6):e13585
pubmed: 35315570
J Appl Clin Med Phys. 2005 Spring;6(2):62-73
pubmed: 15940213
Phys Imaging Radiat Oncol. 2020 Nov 09;16:113-129
pubmed: 33458354
J Appl Clin Med Phys. 2018 Jul;19(4):98-102
pubmed: 29785729
Med Phys. 2020 Nov;47(11):5419-5427
pubmed: 32964446
Tech Innov Patient Support Radiat Oncol. 2020 Nov 24;16:65-69
pubmed: 33294646
Technol Cancer Res Treat. 2014 Feb;13(1):57-67
pubmed: 23819494
Med Phys. 2013 Nov;40(11):111722
pubmed: 24320430

Auteurs

Ananta Raj Chalise (AR)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California, USA.

Casey Bojechko (C)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH